TY - JOUR
T1 - Developmental Consequences of Defective ATG7-Mediated Autophagy in Humans
T2 - Defective ATG7-Mediated Autophagy in Humans
AU - Collier, Jack J.
AU - Guissart, Claire
AU - Olahova, Monika
AU - Sasorith, Souphatta
AU - Piron-Prunier, Florence
AU - Suomi, Fumi
AU - Zhang, David
AU - Martinez-Lopez, Nuria
AU - Leboucq, Nicolas
AU - Bahr, Angela
AU - Azzarello-Burri, Silvia
AU - Reich, Selina
AU - Schoels, Ludger
AU - Polvikoski, Tuomo M.
AU - Meyer, Pierre
AU - Larrieu, Lise
AU - Schaefer, Andrew M
AU - Alsaif, Hessa S.
AU - Alyamani, Suad
AU - Zuchner, Stephan
AU - Barbosa, Ines A.
AU - Deshpande, Charu
AU - Pyle, Angela
AU - Rauch, Anita
AU - Synofzik, Matthis
AU - Alkuraya, Fowzan S.
AU - Rivier, Francois
AU - Ryten, Mina
AU - McFarland, Robert
AU - Delahodde, Agnes
AU - McWilliams, Thomas G.
AU - Koenig, Michel
AU - Taylor, Robert W.
PY - 2021/6/24
Y1 - 2021/6/24
N2 - Background Autophagy is the major intracellular degradation route in mammalian cells. Systemic ablation of core autophagy-related (ATG) genes in mice leads to embryonic or perinatal lethality, and conditional models show neurodegeneration. Impaired autophagy has been associated with a range of complex human diseases, yet congenital autophagy disorders are rare.Methods We performed a genetic, clinical, and neuroimaging analysis involving five families. Mechanistic investigations were conducted with the use of patient-derived fibroblasts, skeletal muscle-biopsy specimens, mouse embryonic fibroblasts, and yeast.Results We found deleterious, recessive variants in human ATG7, a core autophagy-related gene encoding a protein that is indispensable to classical degradative autophagy. Twelve patients from five families with distinct ATG7 variants had complex neurodevelopmental disorders with brain, muscle, and endocrine involvement. Patients had abnormalities of the cerebellum and corpus callosum and various degrees of facial dysmorphism. These patients have survived with impaired autophagic flux arising from a diminishment or absence of ATG7 protein. Although autophagic sequestration was markedly reduced, evidence of basal autophagy was readily identified in fibroblasts and skeletal muscle with loss of ATG7. Complementation of different model systems by deleterious ATG7 variants resulted in poor or absent autophagic function as compared with the reintroduction of wild-type ATG7.Conclusions We identified several patients with a neurodevelopmental disorder who have survived with a severe loss or complete absence of ATG7, an essential effector enzyme for autophagy without a known functional paralogue. (Funded by the Wellcome Centre for Mitochondrial Research and others.)Genetic Deficit in the Cellular Sanitation System Autophagy is a cellular process through which toxic aggregates, pathogens, and damaged organelles are disposed of and essential metabolites recycled. This study challenges the belief that a core autophagy protein is indispensable.
AB - Background Autophagy is the major intracellular degradation route in mammalian cells. Systemic ablation of core autophagy-related (ATG) genes in mice leads to embryonic or perinatal lethality, and conditional models show neurodegeneration. Impaired autophagy has been associated with a range of complex human diseases, yet congenital autophagy disorders are rare.Methods We performed a genetic, clinical, and neuroimaging analysis involving five families. Mechanistic investigations were conducted with the use of patient-derived fibroblasts, skeletal muscle-biopsy specimens, mouse embryonic fibroblasts, and yeast.Results We found deleterious, recessive variants in human ATG7, a core autophagy-related gene encoding a protein that is indispensable to classical degradative autophagy. Twelve patients from five families with distinct ATG7 variants had complex neurodevelopmental disorders with brain, muscle, and endocrine involvement. Patients had abnormalities of the cerebellum and corpus callosum and various degrees of facial dysmorphism. These patients have survived with impaired autophagic flux arising from a diminishment or absence of ATG7 protein. Although autophagic sequestration was markedly reduced, evidence of basal autophagy was readily identified in fibroblasts and skeletal muscle with loss of ATG7. Complementation of different model systems by deleterious ATG7 variants resulted in poor or absent autophagic function as compared with the reintroduction of wild-type ATG7.Conclusions We identified several patients with a neurodevelopmental disorder who have survived with a severe loss or complete absence of ATG7, an essential effector enzyme for autophagy without a known functional paralogue. (Funded by the Wellcome Centre for Mitochondrial Research and others.)Genetic Deficit in the Cellular Sanitation System Autophagy is a cellular process through which toxic aggregates, pathogens, and damaged organelles are disposed of and essential metabolites recycled. This study challenges the belief that a core autophagy protein is indispensable.
KW - 3124 Neurology and psychiatry
KW - 3112 Neurosciences
KW - 3111 Biomedicine
KW - 1184 Genetics, developmental biology, physiology
KW - 1182 Biochemistry, cell and molecular biology
KW - ASSAY
KW - NEURODEGENERATION
KW - HYPOPLASIA
KW - MUTATIONS
KW - ATG7
U2 - 10.1056/NEJMoa1915722
DO - 10.1056/NEJMoa1915722
M3 - Article
SN - 0028-4793
VL - 384
SP - 2406
EP - 2417
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 25
ER -